Mineralocorticoid receptors and the heart, multiple cell types and multiple mechanisms: a focus on the cardiomyocyte

LA Bienvenu, ME Reichelt, LMD Delbridge… - Clinical …, 2013 - portlandpress.com
MR (mineralocorticoid receptor) activation in the heart plays a central role in the
development of cardiovascular disease, including heart failure. The MR is present in many …

Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Diabetic Nephropathy: Miniperspective

DW Piotrowski - Journal of Medicinal Chemistry, 2012 - ACS Publications
Since the discovery of aldosterone over 50 years ago, many facets of its biological action
have been elucidated. 1 Aldosterone is the primary endogenous agonist ligand for the …

[PDF][PDF] Potential involvement of mineralocorticoid receptor activation in the pathogenesis of central serous chorioretinopathy: case report

A Gruszka - Eur Rev Med Pharmacol Sci, 2013 - europeanreview.org
BACKGROUND: Recently it has been suggested that excessive glucocorticoiddependent
choroidal mineralocorticoid receptor (MR) activation may be involved in the pathogenesis of …

Myeloid cells are capable of synthesizing aldosterone to exacerbate damage in muscular dystrophy

JA Chadwick, SA Swager, J Lowe… - Human molecular …, 2016 - academic.oup.com
FDA-approved mineralocorticoid receptor (MR) antagonists are used to treat heart failure.
We have recently demonstrated efficacy of MR antagonists for skeletal muscles in addition to …

Corticosteroid and progesterone transactivation of mineralocorticoid receptors from Amur sturgeon and tropical gar

A Sugimoto, K Oka, R Sato, S Adachi… - Biochemical …, 2016 - portlandpress.com
The response to a panel of steroids by the mineralocorticoid receptor (MR) from Amur
sturgeon and tropical gar, two basal ray-finned fish, expressed in HEK293 cells was …

Formation of threohydrobupropion from bupropion is dependent on 11β-hydroxysteroid dehydrogenase 1

A Meyer, A Vuorinen, AE Zielinska, P Strajhar… - Drug Metabolism and …, 2013 - ASPET
Bupropion is widely used for treatment of depression and as a smoking-cessation drug.
Despite more than 20 years of therapeutic use, its metabolism is not fully understood. While …

The role of the mineralocorticoid receptor and mineralocorticoid receptor–directed therapies in heart failure

MJ Young, M Kanki, N Karthigan… - …, 2021 - academic.oup.com
Mineralocorticoid receptor (MR) antagonists (MRA), also referred to as aldosterone blockers,
are now well-recognized for their clinical benefit in patients who have heart failure (HF) with …

11β-HSD1 inhibition reduces atherosclerosis in mice by altering proinflammatory gene expression in the vasculature

MJ Luo, R Thieringer, MS Springer… - Physiological …, 2013 - journals.physiology.org
11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) is implicated in the etiology of
metabolic syndrome. We previously showed that pharmacological inhibition of 11β-HSD1 …

Pharmacophore Model Refinement for 11β‐Hydroxysteroid Dehydrogenase Inhibitors: Search for Modulators of Intracellular Glucocorticoid Concentrations

A Vuorinen, LG Nashev, A Odermatt… - Molecular …, 2014 - Wiley Online Library
Abstract 11β‐Hydroxysteroid dehydrogenases (11β‐HSD) control the intracellular
concentrations of glucocorticoids: 11β‐HSD1 converts the inactive cortisone to the active …

Gene expression effects of glucocorticoid and mineralocorticoid receptor agonists and antagonists on normal human skeletal muscle

JA Chadwick, JS Hauck… - Physiological …, 2017 - journals.physiology.org
Mineralocorticoid and glucocorticoid receptors are closely related steroid hormone receptors
that regulate gene expression through many of the same hormone response elements …